Is speech function lateralised in the basal ganglia? Evidence from de novo Parkinson's disease

J Neurol Neurosurg Psychiatry. 2025 Apr 10;96(5):462-465. doi: 10.1136/jnnp-2024-334297.

Abstract

Background: Research on the possible influence of lateralised basal ganglia dysfunction on speech in Parkinson's disease is scarce. This study aimed to compare speech in de-novo, drug-naive patients with Parkinson's disease (PD) with asymmetric nigral dopaminergic dysfunction, predominantly in either the right or left hemisphere.

Methods: Acoustic analyses of reading passages were performed. Asymmetry of nigral dysfunction was defined using dopamine transporter-single-photon emission CT (DAT-SPECT).

Results: From a total of 135 de novo patients with PD assessed, 47 patients had a lower right and 36 lower left DAT availability in putamen based on DAT-SPECT. Patients with PD with lower left DAT availability had higher dysarthria severity via composite dysarthria index compared with patients with lower right DAT availability (p=0.01).

Conclusion: Our data support the crucial role of DAT availability in the left putamen in speech. This finding might provide important clues for managing speech following deep brain stimulation.

Keywords: MOTOR CONTROL; MOVEMENT DISORDERS; PARKINSON'S DISEASE; SPEECH.

MeSH terms

  • Aged
  • Basal Ganglia* / diagnostic imaging
  • Basal Ganglia* / physiopathology
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Dysarthria / diagnostic imaging
  • Dysarthria / etiology
  • Dysarthria / physiopathology
  • Female
  • Functional Laterality* / physiology
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease* / complications
  • Parkinson Disease* / diagnostic imaging
  • Parkinson Disease* / physiopathology
  • Putamen / diagnostic imaging
  • Putamen / metabolism
  • Putamen / physiopathology
  • Speech* / physiology
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Dopamine Plasma Membrane Transport Proteins